DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERSPRNewsWire • 12/14/22
Seer's Proteomics Platform Named as Top 10 Innovation in 2022 by The ScientistGlobeNewsWire • 12/12/22
Seer, Inc. (SEER) CEO Omid Farokhzad on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 11/09/22
Seer Announces Publication of Seminal Study Demonstrating the Power of Engineered Nano-Bio Interactions to Enable Deep Access to the ProteomeGlobeNewsWire • 08/23/22
Seer, Inc. (SEER) CEO Omid Farokhzad on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/13/22
Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph™ Analysis Suite 2.0GlobeNewsWire • 08/03/22
Seer, Inc. (SEER) CEO Omid Farokhzad on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/07/22
Analysts Estimate Seer, Inc. (SEER) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/27/22
ROSEN, A LEADING LAW FIRM, Encourages Seer, Inc. Investors With Losses to Inquire About Class Action Investigation - SEERPRNewsWire • 04/05/22
SEER SHAREHOLDER ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Seer, Inc. Investors with Losses to Inquire About Class Action Investigation - SEERNewsfile Corp • 04/01/22
Seer Announces Publication of Seminal Study Demonstrating Superior Performance of Technology Platform for Deep, Unbiased, Precise, Scalable Proteomics in the Proceedings of the National Academy of SciencesGlobeNewsWire • 03/14/22
Seer, Inc. (SEER) CEO Omid Farokhzad on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22
Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 OutlookGlobeNewsWire • 02/28/22